Fruth Investment Management lowered its stake in Ingevity Co. (NYSE:NGVT – Free Report) by 1.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,618 shares of the company’s stock after selling 230 shares during the quarter. Fruth Investment Management’s holdings in Ingevity were worth $717,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in NGVT. KBC Group NV raised its holdings in Ingevity by 27.5% during the fourth quarter. KBC Group NV now owns 2,007 shares of the company’s stock valued at $82,000 after buying an additional 433 shares in the last quarter. Mitsubishi UFJ Asset Management UK Ltd. acquired a new position in Ingevity during the 4th quarter worth $530,000. Hennion & Walsh Asset Management Inc. bought a new stake in Ingevity during the fourth quarter valued at about $239,000. Moody National Bank Trust Division grew its position in shares of Ingevity by 12.4% in the fourth quarter. Moody National Bank Trust Division now owns 41,837 shares of the company’s stock valued at $1,705,000 after purchasing an additional 4,608 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Ingevity by 24.9% in the third quarter. JPMorgan Chase & Co. now owns 117,581 shares of the company’s stock worth $4,586,000 after purchasing an additional 23,460 shares during the period. 91.59% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, BMO Capital Markets raised their target price on Ingevity from $40.00 to $47.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Ingevity presently has a consensus rating of “Moderate Buy” and a consensus target price of $52.17.
Ingevity Price Performance
NGVT stock opened at $44.55 on Thursday. The business’s 50-day simple moving average is $43.84 and its 200 day simple moving average is $40.98. The company has a debt-to-equity ratio of 6.52, a current ratio of 1.76 and a quick ratio of 1.04. Ingevity Co. has a twelve month low of $30.90 and a twelve month high of $56.29.
Ingevity Company Profile
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Further Reading
- Five stocks we like better than Ingevity
- The How And Why of Investing in Oil Stocks
- Powering Profits: Utility Stocks That Shine in Volatility
- Roth IRA Calculator: Calculate Your Potential Returns
- Cirrus Logic Upgraded After Q3 Earnings Beat—More Gains Ahead?
- How to Use the MarketBeat Excel Dividend Calculator
- RTX and Lockheed Martin: Buy 1 for Today and 1 for Tomorrow
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.